← FDA Drug Approvals (Drugs@FDA)

LAPATINIB DITOSYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2024-08-16

Drug application

FDA Application #

ANDA217968

Application type

Abbreviated New Drug Application (Generic)

Brand name

LAPATINIB DITOSYLATE

Generic name

LAPATINIB

Active ingredients

LAPATINIB DITOSYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS USA INC

Manufacturer

Teva Pharmaceuticals, Inc.

First approval

2024-08-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown